Search
Now showing items 1-10 of 13
Results of the CAPSID randomized trial for high-dose convalescent plasma in patients with severe COVID-19
Körper, Sixten et al. (2021)
Wissenschaftlicher Artikel
Multi-platform profiling characterizes molecular subgroups and resistance networks in chronic lymphocytic leukemia
Bloehdorn, Johannes et al. (2021)
Wissenschaftlicher Artikel
Differences in expression and function of LEF1 isoforms in normal versus leukemic hematopoiesis
Feder, Kristin et al. (2020)
Wissenschaftlicher Artikel
Elevated Hedgehog activity contributes to attenuated DNA damage responses in aged hematopoietic cells
Scheffold, Annika et al. (2020)
Wissenschaftlicher Artikel
A phase II study of the PI3K inhibitor copanlisib in combination with the anti-CD20 monoclonal antibody rituximab for patients with marginal zone lymphoma: treatment rationale and protocol design of the COUP-1 trial
Grunenberg, Alexander et al. (2021)
Wissenschaftlicher Artikel
Noncatalytic Bruton's tyrosine kinase activates PLC?(2) variants mediating ibrutinib resistance in human chronic lymphocytic leukemia cells
Wist, Martin et al. (2020)
Wissenschaftlicher Artikel
MicroRNA-708 is a novel regulator of the Hoxa9 program in myeloid cells
Schneider, Edith et al. (2020)
Wissenschaftlicher Artikel
Genomic alterations in high-risk chronic lymphocytic leukemia frequently affect cell cycle key regulators and NOTCH1-regulated transcription
Edelmann, Jennifer et al. (2020)
Wissenschaftlicher Artikel
Phase II trial evaluating the efficacy and safety of the anti-CD20 monoclonal antibody obinutuzumab in patients with marginal zone lymphoma
Grunenberg, Alexander et al. (2020)
Wissenschaftlicher Artikel
Rituximab and obinutuzumab differentially hijack the B cell receptor and NOTCH1 signaling pathways
Edelmann, Jennifer et al. (2021)
Wissenschaftlicher Artikel